Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects
Is a
Allocation Type
Non-Randomized
0
Health Conditions in Trial
Intervention Model
Parallel Assignment
0
Intervention Name
MVA-BN-WEV Dose 3
0
MVA-BN-WEV Dose 2
0
MVA-BN-WEV Dose 1
0
Interventional Trial Phase
Phase 1
0
Interventional Trial Purpose
Prevention
0
Intervention Type
Biological
0
Last Updated
August 20, 2020
0
Masking Type
None (Open Label)
0
Primary Completion Date
July 22, 2020
0
Trial Recruitment Size
45
0
Trial Sponsor
Clinical Trial Start Date
October 7, 2019
0
Study Completion Date
July 22, 2020
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
Phase 1 Vaccination Trial to Evaluate Safety, Tolerability and Immunogenicity of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects
0
Official Website
Find more entities like Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
